<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Corrigendum: Milk ladder: Who? When? How? Where? with the lowest risk of reaction

Loading...
Thumbnail Image

Departments

Item type:Organizational Unit,
Item type:Organizational Unit,

School / College / Institute

Item type:Organizational Unit,
GRADUATE SCHOOL OF HEALTH SCIENCES
Upper Org Unit
Item type:Organizational Unit,
SCHOOL OF MEDICINE
Upper Org Unit

Program

Organization Authors

Co-Authors

Soyer, Özge

Bingöl, Gülbin

Can, Ceren

Nacaroğlu, Hikmet Tekin

Bingöl, Ayşen

Yılmaz, Ebru Arık

Aydoğan, Metin

Date

Language

Type

Embargo Status

No

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

The milk ladder (ML) approach, which is the gradual reintroduction of the milk allergen from the least allergenic forms to the most allergenic forms into the diet of the patients, has been utilized mostly in non-IgE-mediated but in some countries also in IgE-mediated-CMPA due to its possible benefits which include nutrition, quality of life and tolerance induction. Despite increasing interest, so far, there is no guideline on ML; thus, the use of this approach shows discrepancies among healthcare professionals as many factors such as dietary habits, patient history, test results, workload, and facilities of the hospitals, the anxiety of the parents/patients may affect the decision on how, when, where and whom to use ML. Here, we reviewed current data on implementing the ML, suggested a 4-step ML including receipts and amounts, and shared our experience on optimal patient selection, appropriate time and steps for initiating ML, and time intervals between the steps targeting the lowest risk of reaction. We also added the newly developed twice-baked biscotti cake to the ML. We presented the analyses of this product, showing its low allergenicity compared to conventional cake, which provides a safer introduction of milk into the diet.

Source

Publisher

Frontiers

Subject

Citation

item.page.haspartof

Source

Frontiers in allergy

item.page.ispartofseries

item.page.edition

DOI

10.3389/falgy.2025.1576302

item.page.datauri

item.page.link

Rights

CC BY (Attribution)

Copyrights Note

Creative Commons license

Except where otherwise noted, this item's license is described as CC BY (Attribution)

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Google Scholar
Scholar'da Ara ↗
3
Görüntülenme
15
İndirme
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators